ID   TARA_HUMAN              Reviewed;        2365 AA.
AC   Q9H2D6; B1AHD4; B1AHD7; F2Z2W0; F8W6V6; O94797; Q2PZW8; Q2Q3Z9; Q2Q400;
AC   Q5R3M6; Q96DW1; Q9BT77; Q9BTL7; Q9BY98; Q9Y3L4;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 3.
DT   28-JUN-2023, entry version 193.
DE   RecName: Full=TRIO and F-actin-binding protein;
DE   AltName: Full=Protein Tara;
DE   AltName: Full=Trio-associated repeat on actin;
GN   Name=TRIOBP; Synonyms=KIAA1662, TARA; ORFNames=HRIHFB2122;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH TRIO AND
RP   ACTIN.
RX   PubMed=11148140; DOI=10.1242/jcs.114.2.389;
RA   Seipel K., O'Brien S.P., Iannotti E., Medley Q.G., Streuli M.;
RT   "Tara, a novel F-actin binding protein, associates with the Trio guanine
RT   nucleotide exchange factor and regulates actin cytoskeletal organization.";
RL   J. Cell Sci. 114:389-399(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 4 AND 5), AND INVOLVEMENT IN
RP   DFNB28.
RC   TISSUE=Inner ear;
RX   PubMed=16385457; DOI=10.1086/499164;
RA   Riazuddin S., Khan S.N., Ahmed Z.M., Ghosh M., Caution K., Nazli S.,
RA   Kabra M., Zafar A.U., Chen K., Naz S., Antonellis A., Pavan W.J.,
RA   Green E.D., Wilcox E.R., Friedman P.L., Morell R.J., Riazuddin S.,
RA   Friedman T.B.;
RT   "Mutations in TRIOBP, which encodes a putative cytoskeletal-organizing
RT   protein, are associated with nonsyndromic recessive deafness.";
RL   Am. J. Hum. Genet. 78:137-143(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND VARIANTS
RP   DFNB28 ARG-1019 AND ARG-1377.
RC   TISSUE=Brain;
RX   PubMed=16385458; DOI=10.1086/499495;
RA   Shahin H., Walsh T., Sobe T., Abu Sa'ed J., Abu Rayan A., Lynch E.D.,
RA   Lee M.K., Avraham K.B., King M.-C., Kanaan M.;
RT   "Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin
RT   binding protein are responsible for DFNB28 recessive nonsyndromic hearing
RT   loss.";
RL   Am. J. Hum. Genet. 78:144-152(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 2-431 (ISOFORM 6).
RC   TISSUE=Colon, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 340-563, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Fetal brain;
RX   PubMed=9853615; DOI=10.1038/4315;
RA   Ueki N., Oda T., Kondo M., Yano K., Noguchi T., Muramatsu M.-A.;
RT   "Selection system for genes encoding nuclear-targeted proteins.";
RL   Nat. Biotechnol. 16:1338-1342(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 713-2365, AND VARIANT ARG-1377.
RC   TISSUE=Brain;
RX   PubMed=11258795; DOI=10.1093/dnares/8.1.1;
RA   Hirosawa M., Nagase T., Murahashi Y., Kikuno R., Ohara O.;
RT   "Identification of novel transcribed sequences on human chromosome 22 by
RT   expressed sequence tag mapping.";
RL   DNA Res. 8:1-9(2001).
RN   [8]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [9]
RP   FUNCTION, INTERACTION WITH HECTD3, AND UBIQUITINATION.
RX   PubMed=18194665; DOI=10.1016/j.bbrc.2008.01.022;
RA   Yu J., Lan J., Zhu Y., Li X., Lai X., Xue Y., Jin C., Huang H.;
RT   "The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of
RT   Tara.";
RL   Biochem. Biophys. Res. Commun. 367:805-812(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1949 AND SER-1955, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1955, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1949 AND SER-1955, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION AT THR-457 (ISOFORM 1), AND SUBCELLULAR LOCATION (ISOFORM
RP   1).
RX   PubMed=22820163; DOI=10.1016/j.yexcr.2012.07.001;
RA   Zhu Y., Wang C., Lan J., Yu J., Jin C., Huang H.;
RT   "Phosphorylation of Tara by Plk1 is essential for faithful chromosome
RT   segregation in mitosis.";
RL   Exp. Cell Res. 318:2344-2352(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1955, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1796, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: May regulate actin cytoskeletal organization, cell spreading
CC       and cell contraction by directly binding and stabilizing filamentous F-
CC       actin. The localized formation of TARA and TRIO complexes coordinates
CC       the amount of F-actin present in stress fibers. May also serve as a
CC       linker protein to recruit proteins required for F-actin formation and
CC       turnover. {ECO:0000269|PubMed:18194665}.
CC   -!- SUBUNIT: Binds to TRIO and F-actin (PubMed:11148140). May also interact
CC       with myosin II (PubMed:11148140). Interacts with HECTD3
CC       (PubMed:18194665). Interacts with PJVK (By similarity).
CC       {ECO:0000250|UniProtKB:Q99KW3, ECO:0000269|PubMed:11148140,
CC       ECO:0000269|PubMed:18194665}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9853615}. Cytoplasm,
CC       cytoskeleton {ECO:0000269|PubMed:9853615}. Note=Localized to F-actin in
CC       a periodic pattern. {ECO:0000269|PubMed:9853615}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus
CC       {ECO:0000269|PubMed:22820163}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:22820163}. Midbody
CC       {ECO:0000269|PubMed:22820163}. Note=Centrosomal localization occurs
CC       upon phosphorylation by PLK1 at Thr-457 and lasts from prophase to
CC       anaphase. At telophase, relocalizes to midbody.
CC       {ECO:0000269|PubMed:22820163}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=2; Synonyms=TRIOBP-6;
CC         IsoId=Q9H2D6-1; Sequence=Displayed;
CC       Name=3; Synonyms=Long isoform;
CC         IsoId=Q9H2D6-2; Sequence=VSP_017714, VSP_017715, VSP_017717;
CC       Name=4; Synonyms=TRIOBP-3;
CC         IsoId=Q9H2D6-3; Sequence=VSP_017712;
CC       Name=5; Synonyms=TRIOBP-4;
CC         IsoId=Q9H2D6-4; Sequence=VSP_017712, VSP_017713;
CC       Name=1; Synonyms=TRIOBP-1;
CC         IsoId=Q9H2D6-5; Sequence=VSP_017711, VSP_017716;
CC       Name=6;
CC         IsoId=Q9H2D6-6; Sequence=VSP_047498, VSP_047499, VSP_047500,
CC                                  VSP_047501;
CC       Name=7;
CC         IsoId=Q9H2D6-7; Sequence=VSP_047498, VSP_047499;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in heart and
CC       placenta. Isoform 3 is expressed in fetal brain, retina and cochlea but
CC       is not detectable in the other tissues. {ECO:0000269|PubMed:16385458}.
CC   -!- DOMAIN: Contains at least 2 actin-binding sites per coiled-coil dimer.
CC   -!- PTM: Ubiquitinated by HECTD3, leading to its degradation by the
CC       proteasome. {ECO:0000269|PubMed:18194665}.
CC   -!- PTM: [Isoform 1]: Phosphorylation at Thr-457 by PLK1 ensures mitotic
CC       progression and is essential for accurate chromosome segregation.
CC       {ECO:0000269|PubMed:22820163}.
CC   -!- DISEASE: Deafness, autosomal recessive, 28 (DFNB28) [MIM:609823]: A
CC       form of non-syndromic sensorineural hearing loss. Sensorineural
CC       deafness results from damage to the neural receptors of the inner ear,
CC       the nerve pathways to the brain, or the area of the brain that receives
CC       sound information. {ECO:0000269|PubMed:16385457,
CC       ECO:0000269|PubMed:16385458}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Has been identified by a selection system for genes
CC       encoding nuclear-targeted protein. {ECO:0000269|PubMed:9853615}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA34800.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF281030; AAG44841.1; -; mRNA.
DR   EMBL; DQ228003; ABB59559.1; -; mRNA.
DR   EMBL; DQ228004; ABB59560.1; -; mRNA.
DR   EMBL; DQ228005; ABB59561.1; -; mRNA.
DR   EMBL; DQ278603; ABB77204.1; -; mRNA.
DR   EMBL; Z83844; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003618; AAH03618.1; -; mRNA.
DR   EMBL; BC004303; AAH04303.1; -; mRNA.
DR   EMBL; BC013278; AAH13278.2; -; mRNA.
DR   EMBL; BC022200; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AB015343; BAA34800.1; ALT_FRAME; mRNA.
DR   EMBL; AB051449; BAB33332.2; -; mRNA.
DR   CCDS; CCDS33644.1; -. [Q9H2D6-6]
DR   CCDS; CCDS43015.1; -. [Q9H2D6-1]
DR   CCDS; CCDS43016.1; -. [Q9H2D6-7]
DR   RefSeq; NP_001034230.1; NM_001039141.2. [Q9H2D6-1]
DR   RefSeq; NP_008963.3; NM_007032.5. [Q9H2D6-7]
DR   RefSeq; NP_619538.2; NM_138632.2. [Q9H2D6-6]
DR   AlphaFoldDB; Q9H2D6; -.
DR   SMR; Q9H2D6; -.
DR   BioGRID; 116261; 130.
DR   IntAct; Q9H2D6; 63.
DR   MINT; Q9H2D6; -.
DR   STRING; 9606.ENSP00000384312; -.
DR   GlyGen; Q9H2D6; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q9H2D6; -.
DR   PhosphoSitePlus; Q9H2D6; -.
DR   SwissPalm; Q9H2D6; -.
DR   BioMuta; TRIOBP; -.
DR   DMDM; 90110075; -.
DR   EPD; Q9H2D6; -.
DR   jPOST; Q9H2D6; -.
DR   MassIVE; Q9H2D6; -.
DR   MaxQB; Q9H2D6; -.
DR   PaxDb; Q9H2D6; -.
DR   PeptideAtlas; Q9H2D6; -.
DR   ProteomicsDB; 23821; -.
DR   ProteomicsDB; 29844; -.
DR   ProteomicsDB; 80531; -. [Q9H2D6-1]
DR   ProteomicsDB; 80532; -. [Q9H2D6-2]
DR   ProteomicsDB; 80533; -. [Q9H2D6-3]
DR   ProteomicsDB; 80534; -. [Q9H2D6-4]
DR   ProteomicsDB; 80535; -. [Q9H2D6-5]
DR   Antibodypedia; 288; 137 antibodies from 25 providers.
DR   DNASU; 11078; -.
DR   Ensembl; ENST00000403663.6; ENSP00000386026.2; ENSG00000100106.22. [Q9H2D6-7]
DR   Ensembl; ENST00000407319.7; ENSP00000383913.2; ENSG00000100106.22. [Q9H2D6-6]
DR   Ensembl; ENST00000644935.1; ENSP00000496394.1; ENSG00000100106.22. [Q9H2D6-1]
DR   GeneID; 11078; -.
DR   KEGG; hsa:11078; -.
DR   MANE-Select; ENST00000644935.1; ENSP00000496394.1; NM_001039141.3; NP_001034230.1.
DR   UCSC; uc003atr.4; human. [Q9H2D6-1]
DR   AGR; HGNC:17009; -.
DR   CTD; 11078; -.
DR   DisGeNET; 11078; -.
DR   GeneCards; TRIOBP; -.
DR   GeneReviews; TRIOBP; -.
DR   HGNC; HGNC:17009; TRIOBP.
DR   HPA; ENSG00000100106; Low tissue specificity.
DR   MalaCards; TRIOBP; -.
DR   MIM; 609761; gene.
DR   MIM; 609823; phenotype.
DR   neXtProt; NX_Q9H2D6; -.
DR   OpenTargets; ENSG00000100106; -.
DR   Orphanet; 90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB.
DR   PharmGKB; PA142670699; -.
DR   VEuPathDB; HostDB:ENSG00000100106; -.
DR   eggNOG; KOG4807; Eukaryota.
DR   GeneTree; ENSGT00940000157340; -.
DR   HOGENOM; CLU_231134_0_0_1; -.
DR   InParanoid; Q9H2D6; -.
DR   OMA; YIPPAVC; -.
DR   OrthoDB; 2961037at2759; -.
DR   PhylomeDB; Q9H2D6; -.
DR   TreeFam; TF343361; -.
DR   PathwayCommons; Q9H2D6; -.
DR   Reactome; R-HSA-9662360; Sensory processing of sound by inner hair cells of the cochlea.
DR   Reactome; R-HSA-9662361; Sensory processing of sound by outer hair cells of the cochlea.
DR   SignaLink; Q9H2D6; -.
DR   SIGNOR; Q9H2D6; -.
DR   BioGRID-ORCS; 11078; 18 hits in 1161 CRISPR screens.
DR   ChiTaRS; TRIOBP; human.
DR   GeneWiki; TRIOBP; -.
DR   GenomeRNAi; 11078; -.
DR   Pharos; Q9H2D6; Tbio.
DR   PRO; PR:Q9H2D6; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q9H2D6; protein.
DR   Bgee; ENSG00000100106; Expressed in lower lobe of lung and 206 other tissues.
DR   ExpressionAtlas; Q9H2D6; baseline and differential.
DR   Genevisible; Q9H2D6; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0030496; C:midbody; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0120044; C:stereocilium base; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IDA:MGI.
DR   GO; GO:0045159; F:myosin II binding; NAS:UniProtKB.
DR   GO; GO:0031267; F:small GTPase binding; NAS:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0030047; P:actin modification; NAS:UniProtKB.
DR   GO; GO:0060088; P:auditory receptor cell stereocilium organization; IEA:Ensembl.
DR   GO; GO:0051016; P:barbed-end actin filament capping; NAS:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IDA:MGI.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   CDD; cd13275; PH_M-RIP; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR039597; M-RIP_PH.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   PANTHER; PTHR17271; PLECKSTRIN HOMOLOGY PH DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR17271:SF10; TRIO AND F-ACTIN-BINDING PROTEIN; 1.
DR   Pfam; PF00169; PH; 1.
DR   SMART; SM00233; PH; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; Alternative splicing; Cell cycle; Cell division;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Deafness; Disease variant;
KW   Methylation; Mitosis; Non-syndromic deafness; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..2365
FT                   /note="TRIO and F-actin-binding protein"
FT                   /id="PRO_0000072433"
FT   DOMAIN          1778..1887
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          48..1106
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1168..1554
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1593..1667
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1679..1751
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1889..2017
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2174..2194
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          2062..2247
FT                   /evidence="ECO:0000255"
FT   COILED          2281..2361
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        120..154
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        234..649
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        662..723
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        736..902
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        914..932
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        942..995
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1191..1209
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1260..1274
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1302..1316
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1327..1355
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1488..1507
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1519..1534
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1594..1608
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1641..1667
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1682..1698
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1724..1738
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1891..1915
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1946..1960
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1964..1994
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1796
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1930
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99KW3"
FT   MOD_RES         1949
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         1955
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..1772
FT                   /note="Missing (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:11148140,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017711"
FT   VAR_SEQ         1..172
FT                   /note="Missing (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:16385457"
FT                   /id="VSP_017712"
FT   VAR_SEQ         1..61
FT                   /note="MEEVPGDALCEHFEANILTQNRCQNCFHPEEAHGARYQELRSPSGAEVPYCD
FT                   LPRCPPAPE -> MGGWKGPGQRRGKEGPEARRRAAERGGGGGGGGVPAPRSPAREPRP
FT                   RSCLLLPPPWGAAMT (in isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_047498"
FT   VAR_SEQ         62..1774
FT                   /note="Missing (in isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_047499"
FT   VAR_SEQ         1317..2365
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:16385457"
FT                   /id="VSP_017713"
FT   VAR_SEQ         1317..1355
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16385458"
FT                   /id="VSP_017714"
FT   VAR_SEQ         1729..1774
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16385458"
FT                   /id="VSP_017715"
FT   VAR_SEQ         1773..1774
FT                   /note="RR -> MT (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:11148140,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017716"
FT   VAR_SEQ         1794..1806
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16385458"
FT                   /id="VSP_017717"
FT   VAR_SEQ         2109..2144
FT                   /note="EACERSLAEMESSHQQVMEELQRHHERELQRLQQEK -> LVGVITVPVLQT
FT                   RPLSSERLCDLPKVTPPAGLKGGI (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_047500"
FT   VAR_SEQ         2145..2365
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_047501"
FT   VARIANT         217
FT                   /note="S -> N (in dbSNP:rs12628603)"
FT                   /id="VAR_059725"
FT   VARIANT         493
FT                   /note="S -> N (in dbSNP:rs4821700)"
FT                   /id="VAR_059726"
FT   VARIANT         817
FT                   /note="T -> S (in dbSNP:rs41302575)"
FT                   /id="VAR_061708"
FT   VARIANT         863
FT                   /note="N -> K (in dbSNP:rs9610841)"
FT                   /id="VAR_051412"
FT   VARIANT         1019
FT                   /note="G -> R (in DFNB28; dbSNP:rs549095193)"
FT                   /evidence="ECO:0000269|PubMed:16385458"
FT                   /id="VAR_025719"
FT   VARIANT         1187
FT                   /note="F -> L (in dbSNP:rs5756795)"
FT                   /id="VAR_059727"
FT   VARIANT         1300
FT                   /note="H -> R (in dbSNP:rs739138)"
FT                   /id="VAR_059728"
FT   VARIANT         1372
FT                   /note="E -> D (in dbSNP:rs8140207)"
FT                   /id="VAR_051413"
FT   VARIANT         1377
FT                   /note="W -> R (in dbSNP:rs8140958)"
FT                   /evidence="ECO:0000269|PubMed:11258795,
FT                   ECO:0000269|PubMed:16385458"
FT                   /id="VAR_051414"
FT   CONFLICT        713..719
FT                   /note="RTTQQEN -> KSTFGCL (in Ref. 7; BAB33332)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1421
FT                   /note="R -> S (in Ref. 3; ABB77204)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1689
FT                   /note="S -> G (in Ref. 3; ABB77204)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1896
FT                   /note="Missing (in Ref. 3; ABB77204)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1904
FT                   /note="N -> D (in Ref. 3; ABB77204)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2114
FT                   /note="S -> T (in Ref. 1; AAG44841)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2141
FT                   /note="Q -> L (in Ref. 5; AAH04303)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2274
FT                   /note="S -> T (in Ref. 1; AAG44841)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2283
FT                   /note="E -> EHLYPQ (in Ref. 5; AAH04303)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2359
FT                   /note="M -> I (in Ref. 1; AAG44841)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q9H2D6-5:457
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:22820163"
SQ   SEQUENCE   2365 AA;  261376 MW;  B2CF9AD57E930283 CRC64;
     MEEVPGDALC EHFEANILTQ NRCQNCFHPE EAHGARYQEL RSPSGAEVPY CDLPRCPPAP
     EDPLSASTSG CQSVVDPGLR PGPKRGPSPS AGLPEEGPTA APRSRSRELE AVPYLEGLTT
     SLCGSCNEDP GSDPTSSPDS ATPDDTSNSS SVDWDTVERQ EEEAPSWDEL AVMIPRRPRE
     GPRADSSQRA PSLLTRSPVG GDAAGQKKED TGGGGRSAGQ HWARLRGESG LSLERHRSTL
     TQASSMTPHS GPRSTTSQAS PAQRDTAQAA STREIPRASS PHRITQRDTS RASSTQQEIS
     RASSTQQETS RASSTQEDTP RASSTQEDTP RASSTQWNTP RASSPSRSTQ LDNPRTSSTQ
     QDNPQTSFPT CTPQRENPRT PCVQQDDPRA SSPNRTTQRE NSRTSCAQRD NPKASRTSSP
     NRATRDNPRT SCAQRDNPRA SSPSRATRDN PTTSCAQRDN PRASRTSSPN RATRDNPRTS
     CAQRDNPRAS SPSRATRDNP TTSCAQRDNP RASRTSSPNR ATRDNPRTSC AQRDNPRASS
     PNRAARDNPT TSCAQRDNPR ASRTSSPNRA TRDNPRTSCA QRDNPRASSP NRATRDNPTT
     SCAQRDNPRA SRTSSPNRAT RDNPRTSCAQ RDNPRASSPN RTTQQDSPRT SCARRDDPRA
     SSPNRTIQQE NPRTSCALRD NPRASSPSRT IQQENPRTSC AQRDDPRASS PNRTTQQENP
     RTSCARRDNP RASSRNRTIQ RDNPRTSCAQ RDNPRASSPN RTIQQENLRT SCTRQDNPRT
     SSPNRATRDN PRTSCAQRDN LRASSPIRAT QQDNPRTCIQ QNIPRSSSTQ QDNPKTSCTK
     RDNLRPTCTQ RDRTQSFSFQ RDNPGTSSSQ CCTQKENLRP SSPHRSTQWN NPRNSSPHRT
     NKDIPWASFP LRPTQSDGPR TSSPSRSKQS EVPWASIALR PTQGDRPQTS SPSRPAQHDP
     PQSSFGPTQY NLPSRATSSS HNPGHQSTSR TSSPVYPAAY GAPLTSPEPS QPPCAVCIGH
     RDAPRASSPP RYLQHDPFPF FPEPRAPESE PPHHEPPYIP PAVCIGHRDA PRASSPPRHT
     QFDPFPFLPD TSDAEHQCQS PQHEPLQLPA PVCIGYRDAP RASSPPRQAP EPSLLFQDLP
     RASTESLVPS MDSLHECPHI PTPVCIGHRD APSFSSPPRQ APEPSLFFQD PPGTSMESLA
     PSTDSLHGSP VLIPQVCIGH RDAPRASSPP RHPPSDLAFL APSPSPGSSG GSRGSAPPGE
     TRHNLEREEY TVLADLPPPR RLAQRQPGPQ AQCSSGGRTH SPGRAEVERL FGQERRKSEA
     AGAFQAQDEG RSQQPSQGQS QLLRRQSSPA PSRQVTMLPA KQAELTRRSQ AEPPHPWSPE
     KRPEGDRQLQ GSPLPPRTSA RTPERELRTQ RPLESGQAGP RQPLGVWQSQ EEPPGSQGPH
     RHLERSWSSQ EGGLGPGGWW GCGEPSLGAA KAPEGAWGGT SREYKESWGQ PEAWEEKPTH
     ELPRELGKRS PLTSPPENWG GPAESSQSWH SGTPTAVGWG AEGACPYPRG SERRPELDWR
     DLLGLLRAPG EGVWARVPSL DWEGLLELLQ ARLPRKDPAG HRDDLARALG PELGPPGTND
     VPEQESHSQP EGWAEATPVN GHSPALQSQS PVQLPSPACT STQWPKIKVT RGPATATLAG
     LEQTGPLGSR STAKGPSLPE LQFQPEEPEE SEPSRGQDPL TDQKQADSAD KRPAEGKAGS
     PLKGRLVTSW RMPGDRPTLF NPFLLSLGVL RWRRPDLLNF KKGWMSILDE PGEPPSPSLT
     TTSTSQWKKH WFVLTDSSLK YYRDSTAEEA DELDGEIDLR SCTDVTEYAV QRNYGFQIHT
     KDAVYTLSAM TSGIRRNWIE ALRKTVRPTS APDVTKLSDS NKENALHSYS TQKGPLKAGE
     QRAGSEVISR GGPRKADGQR QALDYVELSP LTQASPQRAR TPARTPDRLA KQEELERDLA
     QRSEERRKWF EATDSRTPEV PAGEGPRRGL GAPLTEDQQN RLSEEIEKKW QELEKLPLRE
     NKRVPLTALL NQSRGERRGP PSDGHEALEK EVQALRAQLE AWRLQGEAPQ SALRSQEDGH
     IPPGYISQEA CERSLAEMES SHQQVMEELQ RHHERELQRL QQEKEWLLAE ETAATASAIE
     AMKKAYQEEL SRELSKTRSL QQGPDGLRKQ HQSDVEALKR ELQVLSEQYS QKCLEIGALM
     RQAEEREHTL RRCQQEGQEL LRHNQELHGR LSEEIDQLRG FIASQGMGNG CGRSNERSSC
     ELEVLLRVKE NELQYLKKEV QCLRDELQMM QKDKRFTSGK YQDVYVELSH IKTRSEREIE
     QLKEHLRLAM AALQEKESMR NSLAE
//
